Survey: Blood stem cell transplants mostly done in wealthier countries

04/28/2010 | Medscape (free registration)

Hematopoietic stem cell transplantation is becoming adopted as a treatment worldwide, but its use is more common in richer countries, according to a survey by the Worldwide Network for Blood and Marrow Transplantation. The main indications for the use of the stem cell treatment were lymphoproliferative disorders and leukemias, and most of the transplants were done in Europe, the survey showed.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
FDA/Device Technology Attorney
Quarles & Brady
Washington, DC
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Executive Medical Director
Aspirus Network Inc
Wausau, WI
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Director, Membership
The Food and Drug Law Institute
Washington, DC